欢迎来到天天文库
浏览记录
ID:53075963
大小:257.04 KB
页数:3页
时间:2020-04-16
《疏补温肾固肠方治疗腹泻型肠易激综合征的疗效观察-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、疏补温肾固肠方治疗腹泻型肠易激综合征的疗效观察张琼,陈定玉(重庆市中医院,重庆400011)中图分类号R272.1;R574.62文献标志码A文章编号1001.0408(2014)35.3338.03DOI10.6039~.issn.1001—0408.2014.35.24摘要目的:研究疏补温肾固肠方治疗腹泻型肠易激综合征(IBS)的临床疗效。方法:6O例患者随机均分为治疗组和对照组,治疗组使用疏补温肾固肠方,对照组使用匹维溴铵片联合马来酸曲美布汀胶囊。治疗4周后,根据结肠问卷表、大便性状表(IBS.DSQ)、生活质量量表(IB
2、S.QOL)判定疗效。结果:两组患者治疗前后中医症状积分比较,差异均具有统计学意义(P<0.O5),且治疗组优于对照组(P3、固肠方;腹泻型;肠易激综合征;临床疗效EficacyObservationofShubuWenshenGuchangDecoctionintheTreatmentofDiarrhea-predominantIrri-tableBowelSyndromeZHANGQiong,CHENDing—yu(ChongqingHospitalofTCM,Chongqing400011,China)ABSTRACTOBJECTIVE:TostudytheelinicaleficacyofShubuwenshenguchangdecoction4、inthetreatmentofdiarrheapre。dominantirritablebowelsyndrome(IBS).METHODS:60patientswererandomlydividedintotreatmentgroupandcontrolgroup.刚TreatmentgroupreceivedShubuwenshenguchangdecoction,whilecontrolgroupwasgivenPinaveriumbromidetabletsandTrime—butinemaleatecapsules.5、Therapeuticeficacywasevaluatedafter4cycleoftreatmentaccordingtocolonquestionnaire,IBS—DSQandIBS—QOL.RESULTS:TheTCMsymptomscoreof2groupshadstatisticalsignificancebeforeandaftertreatment(P6、ficacyofstoolprofertywas76%intreat—mentgroupand56%incontrolgroup;therewasstatisticalsignificance(P<0.05).Thedefecationtimesandanalbearing—downtimeofIBS—DSQhadstatisticalsignificancebetween2groupsbeforeandaftertreatment(P<0.05),andthoseoftreatmentgroupwerebeRerthantho7、seofcontrolgroup(尸<0.05).TherewasstatisticalsignificanceinIBS-QOLdiference,emotionalstate,mentalstate,dailysocialityandefectsofwork(尸<0.05).CONCLUSIONS:Shubuwenshenguehangdecoctionhasagoodefectondiar-rhea-predominantIBS.KEYWORDSShubuwenshenguchangdecoction;Diarrhea-p8、redominant;Irritablebowelsyndrome;Clinicaleficacy肠易激综合征(IBS)是以腹痛或腹部不适,伴大便性状和大便量≥25%,硬便或块状便占大便量<25%。IBS的发病机排便习惯改变的功能性肠道疾病,是临床最常见的功能性
3、固肠方;腹泻型;肠易激综合征;临床疗效EficacyObservationofShubuWenshenGuchangDecoctionintheTreatmentofDiarrhea-predominantIrri-tableBowelSyndromeZHANGQiong,CHENDing—yu(ChongqingHospitalofTCM,Chongqing400011,China)ABSTRACTOBJECTIVE:TostudytheelinicaleficacyofShubuwenshenguchangdecoction
4、inthetreatmentofdiarrheapre。dominantirritablebowelsyndrome(IBS).METHODS:60patientswererandomlydividedintotreatmentgroupandcontrolgroup.刚TreatmentgroupreceivedShubuwenshenguchangdecoction,whilecontrolgroupwasgivenPinaveriumbromidetabletsandTrime—butinemaleatecapsules.
5、Therapeuticeficacywasevaluatedafter4cycleoftreatmentaccordingtocolonquestionnaire,IBS—DSQandIBS—QOL.RESULTS:TheTCMsymptomscoreof2groupshadstatisticalsignificancebeforeandaftertreatment(P6、ficacyofstoolprofertywas76%intreat—mentgroupand56%incontrolgroup;therewasstatisticalsignificance(P<0.05).Thedefecationtimesandanalbearing—downtimeofIBS—DSQhadstatisticalsignificancebetween2groupsbeforeandaftertreatment(P<0.05),andthoseoftreatmentgroupwerebeRerthantho7、seofcontrolgroup(尸<0.05).TherewasstatisticalsignificanceinIBS-QOLdiference,emotionalstate,mentalstate,dailysocialityandefectsofwork(尸<0.05).CONCLUSIONS:Shubuwenshenguehangdecoctionhasagoodefectondiar-rhea-predominantIBS.KEYWORDSShubuwenshenguchangdecoction;Diarrhea-p8、redominant;Irritablebowelsyndrome;Clinicaleficacy肠易激综合征(IBS)是以腹痛或腹部不适,伴大便性状和大便量≥25%,硬便或块状便占大便量<25%。IBS的发病机排便习惯改变的功能性肠道疾病,是临床最常见的功能性
6、ficacyofstoolprofertywas76%intreat—mentgroupand56%incontrolgroup;therewasstatisticalsignificance(P<0.05).Thedefecationtimesandanalbearing—downtimeofIBS—DSQhadstatisticalsignificancebetween2groupsbeforeandaftertreatment(P<0.05),andthoseoftreatmentgroupwerebeRerthantho
7、seofcontrolgroup(尸<0.05).TherewasstatisticalsignificanceinIBS-QOLdiference,emotionalstate,mentalstate,dailysocialityandefectsofwork(尸<0.05).CONCLUSIONS:Shubuwenshenguehangdecoctionhasagoodefectondiar-rhea-predominantIBS.KEYWORDSShubuwenshenguchangdecoction;Diarrhea-p
8、redominant;Irritablebowelsyndrome;Clinicaleficacy肠易激综合征(IBS)是以腹痛或腹部不适,伴大便性状和大便量≥25%,硬便或块状便占大便量<25%。IBS的发病机排便习惯改变的功能性肠道疾病,是临床最常见的功能性
此文档下载收益归作者所有